RecruitingNot ApplicableNCT06930677
Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200
A Prospective, Single-arm, Multinational, Multi-center, Clinical Study to Evaluate the Performance and Safety of Musculoskeletal Embolization Using NBGM200 in Patients With Knee Degenerative Osteoarthritis
Sponsor
Next Biomedical Co., Ltd.
Enrollment
72 participants
Start Date
Apr 17, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Study in patients with knee osteoarthritis treated by embolization using NBGM200
Eligibility
Min Age: 50 Years
Inclusion Criteria1
- Osteoarthritis proven by MR-imaging
Exclusion Criteria2
- Current local infection
- Life expectancy less than 6 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEembolization therapy
MSK embolization
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06930677
Related Trials
Effects of Core Stabilization Exercises in Female Patients With Gonarthrosis
NCT074823321 location
Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)
NCT070360031 location
Advanced Brain Imaging-TKA (fMRI-TKA)
NCT074640801 location
Analysis of the Loss of Muscle Force, Power and Motor Control to Predict the Risk of Falls in Patients With Knee OA
NCT066116181 location
An Implementation Science Approach to Evaluating Self-Administered Acupressure for Knee Osteoarthritis in Older-Aged Adults in the Community
NCT073290231 location